<DOC>
	<DOCNO>NCT01634321</DOCNO>
	<brief_summary>The purpose Clinical Trial Evaluate Efficacy Safety Luphere Depot Inj . 3.75mg ( Leuprolide acetate 3.75mg ) patient precocious puberty .</brief_summary>
	<brief_title>The Clinical Trial Evaluate Efficacy Safety Luphere Depot Inj . 3.75mg ( Leuprolide Acetate 3.75mg ) Patients With Precocious Puberty</brief_title>
	<detailed_description />
	<mesh_term>Puberty , Precocious</mesh_term>
	<mesh_term>Leuprolide</mesh_term>
	<criteria>4~8 year &amp; tanner stage â‰¥ 2 Previous treatment GnRH analog therapy</criteria>
	<gender>All</gender>
	<minimum_age>4 Years</minimum_age>
	<maximum_age>9 Years</maximum_age>
	<verification_date>August 2014</verification_date>
</DOC>